156 related articles for article (PubMed ID: 24792888)
1. Prognostic value of PDCD6 polymorphisms and the susceptibility to bladder cancer.
Zhou B; Zhang P; Tang T; Zhang K; Wang Y; Song Y; Liao H; Zhang L
Tumour Biol; 2014 Aug; 35(8):7547-54. PubMed ID: 24792888
[TBL] [Abstract][Full Text] [Related]
2. The Contribution of PDCD6 Polymorphisms to Oral Cancer Risk.
Shih LC; He JL; Chang WS; Hsu CL; Hsia TC; Wang YC; Yang JS; Mong MC; Tsai CW; Bau DT
Cancer Genomics Proteomics; 2022; 19(4):456-463. PubMed ID: 35732318
[TBL] [Abstract][Full Text] [Related]
3. Single nucleotide polymorphisms in PDCD6 gene are associated with the development of cervical squamous cell carcinoma.
Zhou B; Bai P; Xue H; Zhang Z; Shi S; Zhang K; Wang Y; Wang K; Quan Y; Song Y; Zhang L
Fam Cancer; 2015 Mar; 14(1):1-8. PubMed ID: 25362542
[TBL] [Abstract][Full Text] [Related]
4. Association between two single nucleotide polymorphisms of PDCD6 gene and increased endometriosis risk.
Shi S; Zhou B; Zhang K; Zhang L
Hum Immunol; 2013 Feb; 74(2):215-8. PubMed ID: 23137875
[TBL] [Abstract][Full Text] [Related]
5. Variations in the PDCD6 gene are associated with increased uterine leiomyoma risk in the Chinese.
Zhang K; Zhou B; Shi S; Song Y; Zhang L
Genet Test Mol Biomarkers; 2013 Jul; 17(7):524-8. PubMed ID: 23551056
[TBL] [Abstract][Full Text] [Related]
6. Contribution of programmed cell death 6 genetic variations, gender, and smoking status to lung cancer.
Shen TC; Chang WS; Hsia TC; Li HT; Chen WC; Tsai CW; Bau DT
Onco Targets Ther; 2019; 12():6237-6244. PubMed ID: 31496727
[TBL] [Abstract][Full Text] [Related]
7. Association between single nucleotide polymorphisms in the programmed cell death 6 gene and the risk of endometrial cancer in Chinese Han women.
Yuan M; Song Y; You D; Li Q; Zhang Y; Zhou B; Zhang L; Xi M
Int J Clin Exp Pathol; 2017; 10(11):11169-11178. PubMed ID: 31966467
[TBL] [Abstract][Full Text] [Related]
8. The role of oncostatin M receptor gene polymorphisms in bladder cancer.
Deng S; He SY; Zhao P; Zhang P
World J Surg Oncol; 2019 Feb; 17(1):30. PubMed ID: 30755233
[TBL] [Abstract][Full Text] [Related]
9. Genetic variation in PDCD6 and susceptibility to lung cancer.
He YQ; Zhou B; Shi SQ; Zhang L; Li WM
Asian Pac J Cancer Prev; 2012; 13(9):4689-93. PubMed ID: 23167403
[TBL] [Abstract][Full Text] [Related]
10. Association of two selected polymorphisms with developed endometriosis in women from Slovakia.
Pitonak J; Galova J; Bernasovska J
Bratisl Lek Listy; 2016; 117(8):452-5. PubMed ID: 27546697
[TBL] [Abstract][Full Text] [Related]
11. Polymorphisms and plasma levels of IL-27: impact on genetic susceptibility and clinical outcome of bladder cancer.
Zhou B; Zhang P; Tang T; Liao H; Zhang K; Pu Y; Chen P; Song Y; Zhang L
BMC Cancer; 2015 May; 15():433. PubMed ID: 26014498
[TBL] [Abstract][Full Text] [Related]
12. Do DNA repair genes OGG1, XRCC3 and XRCC7 have an impact on susceptibility to bladder cancer in the North Indian population?
Gangwar R; Ahirwar D; Mandhani A; Mittal RD
Mutat Res; 2009; 680(1-2):56-63. PubMed ID: 19815090
[TBL] [Abstract][Full Text] [Related]
13. Genetic variants in the tumor necrosis factor-related apoptosis-inducing ligand and death receptor genes contribute to susceptibility to bladder cancer.
Timirci-Kahraman O; Ozkan NE; Turan S; Farooqi AA; Verim L; Ozturk T; Inal-Gultekin G; Isbir T; Ozturk O; Yaylim I
Genet Test Mol Biomarkers; 2015 Jun; 19(6):309-15. PubMed ID: 25955868
[TBL] [Abstract][Full Text] [Related]
14. Genetic variants in NAMPT predict bladder cancer risk and prognosis in individuals from southwest Chinese Han group.
Zhang K; Zhou B; Zhang P; Zhang Z; Chen P; Pu Y; Song Y; Zhang L
Tumour Biol; 2014 May; 35(5):4031-40. PubMed ID: 24363084
[TBL] [Abstract][Full Text] [Related]
15. Caspase 9 and caspase 8 gene polymorphisms and susceptibility to bladder cancer in north Indian population.
Gangwar R; Mandhani A; Mittal RD
Ann Surg Oncol; 2009 Jul; 16(7):2028-34. PubMed ID: 19412632
[TBL] [Abstract][Full Text] [Related]
16. Correlation of IL-31 gene polymorphisms with susceptibility and clinical recurrence of bladder cancer.
Li Q; Tang T; Zhang P; Liu C; Pu Y; Zhang Y; Song H; Wang Y; Song Y; Su M; Zhou B; Zhang L
Fam Cancer; 2018 Oct; 17(4):577-585. PubMed ID: 29116431
[TBL] [Abstract][Full Text] [Related]
17. Association of PDCD6 polymorphisms with the risk of cancer: Evidence from a meta-analysis.
Hashemi M; Bahari G; Markowski J; Małecki A; Łos MJ; Ghavami S
Oncotarget; 2018 May; 9(37):24857-24868. PubMed ID: 29872511
[TBL] [Abstract][Full Text] [Related]
18. Association of IL-12, IL-18 variants and serum IL-18 with bladder cancer susceptibility in North Indian population.
Jaiswal PK; Singh V; Srivastava P; Mittal RD
Gene; 2013 Apr; 519(1):128-34. PubMed ID: 23403235
[TBL] [Abstract][Full Text] [Related]
19. Glutathione S-transferase M1 and T1 polymorphisms: susceptibility and outcomes in muscle invasive bladder cancer patients.
Kang HW; Song PH; Ha YS; Kim WT; Kim YJ; Yun SJ; Lee SC; Choi YH; Moon SK; Kim WJ
Eur J Cancer; 2013 Sep; 49(14):3010-9. PubMed ID: 23810248
[TBL] [Abstract][Full Text] [Related]
20. Association of Matrix Metalloproteinase-7 Genotypes with the Risk of Bladder Cancer.
Liao CH; Chang WS; Tsai CW; Hu PS; Wu HC; Hsu SW; Chen GL; Yueh TC; Shen TC; Hsia TC; Bau DT
In Vivo; 2018; 32(5):1045-1050. PubMed ID: 30388078
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
